Evidence map›Paper›PMID 39981254›Full record

ArticleFrontiers in immunology2025

Comparison of air-liquid interface transwell and airway organoid models for human respiratory virus infection studies.

Camilla T Ekanger, Nilima Dinesh Kumar, Rosanne W Koutstaal, Fan Zhou, Martin Beukema, Joanna Waldock, Simon P Jochems, Noa Mulder, Cécile A C M van Els, Othmar G Engelhardt and 8 more

Abstract readComparative Study
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Organoid scaffold materials: research and application.Frontiers in bioengineering and biotechnology · 2025
    Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Camilla T EkangerDepartment of Biomedicine, Faculty of Medicine, University of Bergen, Bergen, Norway.
Nilima Dinesh KumarDepartment of Medical Microbiology and Infection Prevention, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
Rosanne W KoutstaalCenter for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands.
Fan ZhouInfluenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway.
Martin BeukemaDepartment of Medical Microbiology and Infection Prevention, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
Joanna WaldockInfluenza Resource Centre, Vaccines, Science Research & Innovation, Medicines and Healthcare Products Regulatory Agency (MHRA), Potters Bar, United Kingdom.
Simon P JochemsLeiden University Center for Infectious Diseases (LU-CID), Leiden University Medical Center, Leiden, Netherlands.
Noa MulderGroningen Research Institute for Pharmacy, Department of Molecular Pharmacology, University of Groningen, Groningen, Netherlands.
Cécile A C M van ElsCenter for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands.
Othmar G EngelhardtInfluenza Resource Centre, Vaccines, Science Research & Innovation, Medicines and Healthcare Products Regulatory Agency (MHRA), Potters Bar, United Kingdom.
Nathalie MantelSanofi, Marcy L'Etoile, France.
Kevin P BunoGlaxoSmithKline (GSK), Siena, Italy.
Karl Albert BrokstadInfluenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway.
Agnete S T EngelsenDepartment of Biomedicine, Faculty of Medicine, University of Bergen, Bergen, Norway.
Rebecca J CoxInfluenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway.
Barbro N MelgertGroningen Research Institute for Pharmacy, Department of Molecular Pharmacology, University of Groningen, Groningen, Netherlands.
Anke L W HuckriedeDepartment of Medical Microbiology and Infection Prevention, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
Puck B van KasterenCenter for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Complex Methods: In this study, we compared three different models of human respiratory epithelium: a primary human bronchial epithelial cell-derived ALI transwell model, and two airway organoid models established from human airway- and lung-derived adult stem cells. We first assessed the presence of various differentiated cell types using immunofluorescence microscopy. Using a shared stock of influenza A virus, we then assessed viral growth kinetics, epithelial cytokine responses, and serum-mediated inhibition of infection. Results: The presence of club, goblet, and ciliated cells was confirmed in all models. We observed similar viral replication kinetics with a >4-log increase in virus titre across all models using a TCID50 assay. Following infection, a reproducible antiviral cytokine response, including a consistent increase in CXCL10, IL-6, IFN-λ1, IFN-λ2/3, and IFN-β, was detected across all models. Finally, neutralization was assessed by pre-incubation of virus with human serum. Reduced viral replication was observed across all models, resulting in a 3- to 6-log decrease in virus titres as quantified by TCID50. Discussion: In conclusion, all three models produced consistent results regardless of the varying cell sources, culturing approaches, and infection methods. Our collaborative efforts to harmonize infection experiments and compare ALI transwell and airway organoid models described here aid in advancing our understanding and improving the standardization of these complex

Indexed as

Influenza A virusOrganoidsRespiratory MucosaRespiratory Tract InfectionsCell Culture TechniquesCells, CulturedCytokinesEpithelial CellsHumansVirus ReplicationCytokinescomplex in vitro modelsharmonizationinfluenza virusmucosal modelsrespiratory tract

Identifiers

PMID39981254
PMCPMC11839712

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.